Patterns of sorafenib and TACE treatment of unresectable hepatocellular carcinoma in a Chinese population: subgroup analysis of the GIDEON study
Crossref DOI link: https://doi.org/10.1007/s11033-016-4092-x
Published Online: 2016-12-15
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liu, Fengyong
Meng, Zhiqiang
Shao, Guoliang
Wang, Jianhua
Wang, Zhijun
Yang, Jijin
Yip, Christina S M
He, Dongfeng
License valid from 2016-12-15